Cholinergic immunomodulation in inflammatory bowel diseases

Inflammatory bowel diseases (IBD) are chronic intestinal disorders characterized by dysregulated immune responses to resident microbiota in genetically susceptible hosts. The activation of the cholinergic system has been proposed for the treatment of IBD patients according to its potential anti-infl...

Descripción completa

Detalles Bibliográficos
Autores principales: Serafini, Michele A., Paz, Ana H., Nunes, Natalia S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683952/
https://www.ncbi.nlm.nih.gov/pubmed/34977822
http://dx.doi.org/10.1016/j.bbih.2021.100401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683952/
https://www.ncbi.nlm.nih.gov/pubmed/34977822
http://dx.doi.org/10.1016/j.bbih.2021.100401

Ejemplares similares